Engineering human PON1 in an E. coli expression system

Advances in Experimental Medicine and Biology

Volumn 660, Issue , 2010, Pages 37-45

  Suzuki, Stephanie M ^a   Stevens, Richard C ^a   Richter, Rebecca J ^a   Cole, Toby B ^a   Park, Sarah ^a   Otto, Tamara C ^a   Cerasoli, Douglas M ^a   Lenz, David E ^a   Furlong, Clement E ^a  

^a NONE

Author keywords

Diazoxon; E. coli expression; Engineered PON1; Nerve agents; OP therapy; PON1 knockout mice; Recombinant PON1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; DIAZOXON; ORGANOPHOSPHORUS COMPOUND; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ARTICLE; COLUMN CHROMATOGRAPHY; ENZYME ACTIVITY; ENZYME GLYCOSYLATION; ENZYME PURIFICATION; ENZYME SUBSTRATE; ENZYME SYNTHESIS; ESCHERICHIA COLI; EUKARYOTIC CELL; GENE EXPRESSION SYSTEM; GENETIC ENGINEERING; GENETIC VARIABILITY; INSECTICIDE RESISTANCE; KNOCKOUT MOUSE; MOLECULAR STABILITY; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RISK REDUCTION;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CATALYSIS; ESCHERICHIA COLI; GENETIC ENGINEERING; GLYCOSYLATION; HUMANS; INSECTICIDES; KINETICS; MICE; MICE, KNOCKOUT; ORGANOPHOSPHORUS COMPOUNDS; RECOMBINANT PROTEINS;

BACTERIA (MICROORGANISMS); EUKARYOTA; MUS; ORYCTOLAGUS CUNICULUS; PROKARYOTA;

EID: 79959470990     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-350-3_5     Document Type: Article

References (22)

1. Aharoni A, Gaidukov L, Yagur S, Toker L, Silman I, Tawfik DS (2004) Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc Natl Acad Sci USA 101:482-487 (Pubitemid 38084662)
2. Ashani Y, Shapira S, Levy D, Wolfe AD, Doctor BP, Raveh L (1991) Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem Pharmacol 41: 37-41
3. Bernard P, Couturier M (1992) Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J Mol Biol 226:735-745
4. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV, Lenz DE (1991) Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 259(2):633-638
5. Brushia RJ, Forte TM, Oda MN, La Du BN, Bielicki JK (2001) Baculovirus-mediated expression and purification of human serum paraoxonase 1A. J Lipid Res 42:951-958. (Pubitemid 32545851)
6. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14:334-336
7. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180:242-247 (Pubitemid 19198054)
8. Furlong CE, Richter RJ, Chapline C, Crabb JW (1991) Purification of rabbit and human serum paraoxonase. Biochemistry 30:10133-10140
9. Gan KN, Smolen A, Eckerson HW, La Du BN (1991) Purification of human serum paraoxonase/ arylesterase: Evidence for one esterase catalyzing both activities. Drug Metabolism and Dispos 19:100-106
10. Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RBG, McCarthy A, Toker L, Silman I, Sussman JL, Tawfik DS (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11:412-419 (Pubitemid 38568944)
11. Hassett C, Richter RJ, Humbert R, Chapline C, Crabb JW, Omiecinski CJ, Furlong CE (1991) Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence. Biochemistry 30:10141-10149
12. James RW. (2006) A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin Chem Lab Med 44:1052-1059 (Pubitemid 44370921)
13. Jarvik GP, Rozek LS, Brophy VH, Hatsukami TS, Richter RJ, Schellenberg GD, Furlong CE (2000) Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arterioscler Thromb Vasc Biol 20(11):2441-2447
14. Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli D. (2007) Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 233:31-39 (Pubitemid 46505351)
15. Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, Lusis AJ, Furlong CE (2000) Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10:767-779 (Pubitemid 32042829)
16. Ozer EA, Pezzulo A, Shih DM, Chun C, Furlong C, Lusis AJ, Greenberg EP, Zabner J (2005) Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorumsensing. Fems Microbiol Lett 253:29-37 (Pubitemid 41605391)
17. Raushel FM(2002) Bacterial detoxification of organophosphate nerve agents. Curr Opin Microbiol 5(3):288-295 (Pubitemid 34614941)
18. Shih DM, Gu LJ, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284-287 (Pubitemid 28335041)
19. Sinan S, Kockar F, Arslan O (2006) Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics. Biochimie 88:565-574 (Pubitemid 43870393)
20. Stevens RC, Suzuki SM, Cole TB, Park SS, Richter RJ, Furlong CE (2008) Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc Natl Acad Sci USA 105(35):12780-12784
21. Stoltz DA, Ozer EA, Taft PJ, Barry M, Liu L, Kiss PJ, Moninger TO, Parsek MR, Zabner J (2008) Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1. J Clin Invest 118:3123-3131
22. World Health Organization. Informal consultation on planning strategy for the prevention of pesticide poisoning. Geneva, 25-29 November 1985. WHO/VBC/86. 926. (Geneva: WHO, 1986) World Health Organization. Public health impact of pesticides used in agriculture (Geneva: WHO, 1990)